-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on Lexicon Pharmaceuticals, Raises Price Target to $3.1

Benzinga·05/11/2026 15:10:58
Listen to the news
Citigroup analyst Yigal Nochomovitz maintains Lexicon Pharmaceuticals (NASDAQ:LXRX) with a Buy and raises the price target from $2.3 to $3.1.